Studies in recent years have confirmed that the occurrence of violations in the system of thromboembolism in the pathogenesis of ischemic heart disease and resistance to aspirin almost double the risk of ischemic events. This entails the development of modern approaches aimed at controlling the treatment of ischemic heart disease, the appointment of a timely harmonic antiaggregant treatment plan. The aim of the study is to evaluate the functional status of thrombocytes in patients with stable tension stenocardia (STS) II-III functional class of heart ischemic disease who received acetylsalicylic acid (ASA) for short and long periods. Material and methods. As a source of research, 116 patients treated with a diagnosis of stable tension stenocardia II–III functional class were selected. Patients were divided into four groups according to the duration of admission of acetylsalicylic acid. Patients who received the 1st Group ASA for up to a year, patients who received the 2nd Group ASA for a period of 1 to 5 years, patients who received the 3rd Group ASA for more than 5 years, and patients who did not receive the control group ASA. Platelet aggregation testing was performed on a two – channel laser Alat-2 Biola Analyzer by means of computer processing using traditional turbidometric AGGR program on Born and O'brayen. Results. In the group of patients treated with aspirin for more than 5 years, the rates of spontaneous platelet aggregation and ADP-induced aggregation were higher than in the group of patients treated with ASA for 1 year and treated with ASA for 1 to 5 years, and statistically significant differences were observed compared with the indicators of the group of patients treated with ASA for up to 1 year (spontaneous aggregation of 1.7±0.09 p<0.05, 0.1 µm ADP-induced aggregation of 6.58±0.86 p<0.05, 1.0 ADP-induced aggregation of 16.51±1.63 p<0.01, 5.0 ADP-induced aggregation of 58.44±3.72 p<0.01). In the third group of patients treated with ASA for more than 5 years, resistance to aspirin was significantly more frequent than in the second group of patients treated with ASA for up to 5 years (54.8% and 29%, respectively, Chi2=4.24 r<0.05). And also, in the 1st group of patients treated with ASA before 1 year, the frequency of resistance was observed less than in patients treated with ASA for more than 5 years (13.3% and 54.8%, respectively, Chi2=11.63 r<0.05). Conclusions. In ischemic heart disease treated with aspirin for more than 5 years, an increase in platelet aggregation is associated with the risk of developing resistance to aspirin.
| Mualliflar | Ходжанова Шахноза Искандаровна, Аляви Анис Лутфуллаевич |
|---|---|
| Jurnal | Journal of cardiorespiratory research/Kardiorespirator tadqiqotlar jurnali |
| Nashr sanasi | 2022-07-29 |
| Til | O‘zbek |
ишемическая болезнь сердца, резистентность к аспирину, агрегация тромбоцитов, ischemic heart disease, resistance to aspirin, aggregation of plateletes, yurak ishemik kasalligi, aspiringa rezistentlik, trombositlar agregasiyasi
Our current medicine has been struggling for many years and continues to deal with a decrease in morbidity in the world, and the result of this, as a rule, should be reflected in a decrease in the number of…
This study examined the role of dyslipidemia in the development of coronary heart disease (CHD) in men at a young age. 230 patients with coronary artery disease hospitalized in the departments of somatic resuscitation…
In all countries of the world, chronic obstructive pulmonary disease (COPD) is one of the leading causes of disability and mortality among therapeutic diseases that cause economic and social losses, the level of which…
This article analyzes the clinical features of the course of unstable angina pectoris in men at a young and old age. The study included 230 patients with unstable angina pectoris, which, depending on the age of the…
This review of the literature is devoted to an actual problem in the field of endicrinology, such as DTG. The main clinical manifestations of DTG associated with an excess of thyroid hormones, affecting…
Antibacterial drugs, as well as their combinations, are widely used in clinical practice. Irrational combinations in antibacterial therapy can lead to adverse drug reactions and/or increased costs in the healthcare…
Chronic obstructive pulmonary disease (COPD) is now considered a preventable and treatable disease. Chronic obstructive pulmonary disease (COPD) is a preventable and treatable disease in patients with bronchial…
The use of Thiotriazoline at the outpatient stage in patients with past COVID-19 infection significantly reduces cell damage with a decrease in LDH levels in the main group from 362.5±192.9 to 221.2±98.8 U/l against the…
Chronic heart failure (CHF) is a serious problem for all developed countries of the world, despite significant advances in treatment. In recent years, epidemiologic studies have shown an increase in the prevalence of…
Modern ideas about the clinical picture in P and methods of its diagnosis Should be noted that pneumonia is classified into two types, depending on the conditions under which the disease occurred. These are…
Journal of cardiorespiratory research/Kardiorespirator tadqiqotlar jurnali — barcha maqolalar